As flu season returns, many people find themselves or friends and family members getting caught in the cracks. In the case that traditional anti-influenza drugs such as oseltamivir do not work well in some cases, and even cause adverse reactions such as nausea, vomiting, and anorexia, a new drug, mabaloxavir, has attracted widespread attention with its unique mechanism of action and potential to quickly relieve symptoms.
Learn about mabaloxavir.
Mabaloxavir is a new anti-influenza drug whose mechanism of action is to inhibit the replication and spread of influenza viruses. The highlight of this drug is that it can quickly and effectively relieve various symptoms of the flu, such as fever, cough, sore throat, runny nose, headache, etc.
Advantages of mabaloxavir.
Single dose: Mabaloxavir is designed as a single dose, and patients can feel relief in symptoms within 24 hours.
Broad-spectrum efficacy: It is effective against influenza viruses A, B, and C, and even influenza viruses that have developed resistance to other antiviral drugs.
Limitations of mabaloxavir.
To be clear, mabaloxavir is not a panacea, it does not completely ** the flu, but only relieves symptoms and helps patients feel more comfortable. In patients with severe disease or complications, mabaloxavir may not be sufficient to control the condition and requires a combination of other methods.
Dosage. This product is suitable for ** and adolescents (12 years old), based on body weight dosing regimen:
Patients weigh 40 kg to 80 kg, and a single oral dose of 40 mg is recommended.
The patient weighs 80 kg and the recommended single oral dose is 80 mg.
Dosage adjustment: It is not recommended to reduce the dosage of this product.
Economic considerations. The cost of mabaloxavir is relatively highPreviously, it was 498 yuan before the medical insurance negotiations;After the negotiation of medical insurance, it is currently 22236 yuan, about 111 yuan per pieceThe cost of one ** is more than 200 yuan, which may be a large expense for some families. Therefore, colleagues said that they could not afford to eat, and they could still carry it, hoping to fight the flu through their own immunity.
Overall, mabaloxavir, as a new anti-influenza drug, can quickly relieve flu symptoms and reduce patient discomfort. However, when considering the use of mabaloxavir, patients should consult the advice of a medical professional or pharmacist to ensure that the medication is appropriate for their condition and is used correctly. At the same time, if the financial conditions allow, this drug can be chosen as a means of relieving flu symptoms. For those who are more sensitive, other more affordable anti-influenza drugs may be available or other precautions may be taken to avoid the spread of influenza.